Last reviewed · How we verify
Clonidin
At a glance
| Generic name | Clonidin |
|---|---|
| Sponsor | Medical University of Vienna |
| Target | Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 1, Solute carrier family 22 member 2 |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Approved indications
- Attention deficit hyperactivity disorder
- Hypertensive disorder
- Increased Intraocular Pressure after Ocular Procedure
- Open-angle glaucoma
- Severe pain
Common side effects
- Dry mouth
- Drowsiness
- Dizziness
- Constipation
- Sedation
Serious adverse events
- Congestive heart failure
- Sinus node arrest
- Atrioventricular block
- High degree AV block
- Syncope
- Hallucinations
- Hepatitis
- Pseudo-obstruction
- Thrombocytopenia
- Angioneurotic edema
Key clinical trials
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- Liposomal Bupivacaine With Standard Bupivacaine Versus Dexmedetomidine With Standard Bupivacaine (PHASE3)
- Premedication in Children: a Clinical Trial Comparing Oral Ketamine and Oral Clonidine With Respect to Sedation Level and Opioid Consumption in Pediatrics Undergoing Elective Lower Abdominal Day-case Surgery. (NA)
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients (PHASE2)
- Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty (PHASE4)
- Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study (PHASE1)
- Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder (PHASE4)
- A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clonidin CI brief — competitive landscape report
- Clonidin updates RSS · CI watch RSS
- Medical University of Vienna portfolio CI